ITERATIVE PROTEIN STRUCTURE-BASED DRUG DESIGN AND SYNTHESIS OF HIV PROTEASE INHIBITORS

被引：0

作者：

KALISH, V ^{[1
]}

KALDOR, S ^{[1
]}

SHETTY, B ^{[1
]}

TATLOCK, J ^{[1
]}

DAVIES, J ^{[1
]}

HAMMOND, M ^{[1
]}

DRESSMAN, B ^{[1
]}

FRITZ, J ^{[1
]}

APPELT, K ^{[1
]}

REICH, S ^{[1
]}

MUSICK, L ^{[1
]}

WU, BW ^{[1
]}

SU, K ^{[1
]}

机构：

[1] ELI LILLY & CO,INDIANAPOLIS,IN 46285

来源：

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 1995年 / 30卷

关键词：

HIV PROTEASE INHIBITORS; STRUCTURE-BASED DRUG DESIGN; AG1343; AIDS;

D O I：

暂无

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

下载

页码：S201 / S214

页数：14

共 50 条

[31] Application of EMBM to Structure-Based Design of Warheads for Protease Inhibitors
Traube, Tamar
Shokhen, Michael
Albeck, Amnon
MOLECULAR INFORMATICS, 2014, 33 (01) : 36 - 42
[32] Structure-based design and optimization of potent inhibitors of the adenoviral protease
Grosche, Philipp
Sirockin, Finton
Mac Sweeney, Aengus
Ramage, Paul
Erbel, Paul
Melkko, Samu
Bernardi, Anna
Hughes, Nicola
Ellis, David
Combrink, Keith D.
Jarousse, Nadine
Altmann, Eva
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (03) : 438 - 443
[33] STRUCTURE-BASED, C2 SYMMETRICAL INHIBITORS OF HIV PROTEASE
KEMPF, DJ
NORBECK, DW
CODACOVI, LM
WANG, XC
KOHLBRENNER, WE
WIDEBURG, NE
PAUL, DA
KNIGGE, MF
VASAVANONDA, S
CRAIGKENNARD, A
SALDIVAR, A
ROSENBROOK, W
CLEMENT, JJ
PLATTNER, JJ
ERICKSON, J
JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (10) : 2687 - 2689
[34] Structure-based thermodynamic analysis of HIV-1 protease inhibitors
Bardi, JS
Luque, I
Freire, E
BIOCHEMISTRY, 1997, 36 (22) : 6588 - 6596
[35] Towards structure-based protein drug design
Zhang, Changsheng
Lai, Luhua
BIOCHEMICAL SOCIETY TRANSACTIONS, 2011, 39 : 1382 - 1386
[36] PROTEIN TARGETS FOR STRUCTURE-BASED DRUG DESIGN
WALKINSHAW, MD
MEDICINAL RESEARCH REVIEWS, 1992, 12 (04) : 317 - 372
[37] Development of a protease production platform for structure-based drug design
Fox, Ted
Brennan, Debra
Austen, Douglas A.
Swalley, Susanne E.
Coll, Joyce T.
Raybuck, Scott A.
Chambers, Stephen P.
CURRENT PROTEIN & PEPTIDE SCIENCE, 2007, 8 (05) : 439 - 445
[38] Design and synthesis of depeptidized macrocyclic inhibitors of hepatitis C NS3-4A protease using structure-based drug design
Venkatraman, S
Njoroge, FG
Girijavallabhan, VM
Madison, VS
Yao, NH
Prongay, AJ
Butkiewicz, N
Pichardo, J
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (16) : 5088 - 5091
[39] Structure-based drug design of pyruvate kinase inhibitors
Maxwell, David S.
Peng, Zhenghong
Sun, Duoli
Yung, W. K. Alfred
Lu, Zhimin
Bornmann, William G.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 246
[40] Iterative structure-based design of achiral, non-peptidic anthranilamide and benzamide-containing HIV protease inhibitors as antiviral agents.
Randad, RS
Lubkowska, L
Bhat, TN
Silva, A
Gulnik, S
Yu, B
Erickson, JW
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 211 : 14 - MEDI

← 1 2 3 4 5 →